Treating highly drug-resistant forms of tuberculosis can take anything from nine to 24 months and patients have to contend with various unpleasant, and sometimes dangerous, side effects. A new six-month regimen made up of just three drugs that will be offered to 400 patients in South Africa might offer a better solution for some. Tiyese Jeranji reports.
From March to July this year, the Gauteng Department of Health recorded 57 848 TB tests – a decrease of about 30 000 tests compared to the same period last year. The province performed better with HIV testing, although the HIV response has faltered in other areas. Melissa Javan makes sense of the province’s numbers and speaks to activists and community health workers about the impact of lockdown on their services and plans to get things back on track.
Children shoulder approximately 12% of the global TB burden, and this proportion is likely higher in high TB burden countries. In South Africa, up to 30 000 children develop TB each year. Tiyese Jeranji spoke to TB expert, Dr Megan Palmer from Brooklyn Chest Hospital about treatment challenges and how to improve TB detection and treatment outcomes in children.
Numbers from the National Institute of Communicable Disease and from some provinces show that TB diagnoses have dropped dramatically in 2020 – likely due to COVID-19 and the related lockdown. The Eastern Cape Department of Health has however declined to share information on the TB situation in the province and their catch-up plans. Some activists are concerned about the situation. Luvuyo Mehlwana reports.
A World Health Organization report published last week showed more people are falling ill with tuberculosis in South Africa than previously thought – but also that the country’s treatment success rate for dangerous drug-resistant forms of the disease have improved. Amy Green asks what’s behind these numbers.
People with COVID-19 and people with tuberculosis (TB) can experience similar symptoms such as coughing and breathing difficulties as both diseases affect the lungs. Exactly how these diseases affect the lungs, however, differs. Tiyese Jeranji spoke to a leading South African pulmonologist to learn more.
Some tuberculosis patients in South Africa are still required to take their pills in front of a healthcare worker or family member. Is this a justified means of ensuring people take their medicine, or is it an invasion of personal autonomy? Elri Voigt asked local TB experts.
Even though it has been ready for months, findings of a critically important tuberculosis survey have not been made public. Every day that passes, the more outdated the findings become, and accordingly the less useful.
A leading TB doctor says that “it is no exaggeration to say there is a TB crisis in the country”, and that “the impact of this crisis could be even more devastating than COVID-19”. Kathryn Cleary explores the COVID-19 pandemic’s impact on South Africa’s TB response and the way forward.
It seems HIV and TB are falling by the wayside in the drive to stop the spread of COVID-19. Where we can we must minimise the harm to the HIV and TB response, and we need to see the opportunity to address all three diseases together, writes Erica Penfold.
Tuberculosis (TB) testing rates are down by almost half and dramatically fewer TB patients are starting treatment. Kathryn Cleary takes an in-depth look at the impact of COVID-19 and the lockdown on TB services in South Africa.
In 2018 the United States invested $371 million in tuberculosis research and development (R&D). South Africa invested $4.5 million (R64,9 million) – a dramatic decrease on 2017, but still high when measured as a proportion of all R&D spending in the country.
